REFERENCES
- Sperling L C, Heimer W L. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I. J Am Acad Dermatol 1993; 28: 669–83
- Killinger D W. The role of peripheral metabolism in androgen action. Semin Reprod Endocrinol 1986; 4: 101–8
- Rittmaster R S. Finasteride. N Engl J Med 1994; 330: 120–5
- Dallob A L, Sadick N S, Unger W, et al. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994; 79: 703–6
- Mazzarella F, Loconsole F, Cammisa A, et al. Efficacia della finasteride topica nel trattamento dell'alopecia androgenica. Book of abstracts of the '70dG Congresso della Società Italiana di Dermatologia e Venereologia', S. Margherita di P, Italy, 7–10 June, 1995; 562
- Mazzarella F, Loconsole F, Cammisa A. Esperienze terapeutiche con finasteride topica nell'alopecia androgenetica. Book of abstracts of the 'VII Corso di Aggiornamento in Dermatologia', Roccaraso, Italy, 29 January-3 February, 1996; 73
- Hamilton J B. Patterned loss of hair in man: types and incidence. Ann NY Acad Sci 1951; 53: 708–11
- Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247–54
- Eicheler W, Dreher M, Hoffmann R, et al. Immunohisto-chemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 1995; 133: 371–6
- Thigpen A E, Silver R I, Guileyardo J M, et al. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 1993; 92: 903–10
- Thiboutot D, Harris G, Ilaes V, et al. Activity of type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995; 105: 209–14